Abstract
Sustained blood cell production requires preservation of a quiescent, multipotential stem cell pool that intermittently gives rise to progenitors with robust proliferative potential. The ability of cells to shift from a highly constrained to a vigorously active proliferative state is critical for maintaining stem cells while providing the responsiveness necessary for host defense. The cyclin-dependent kinase inhibitor (CDKI), p21cip1/waf1 (p21) dominates stem cell kinetics. Here we report that another CDKI, p27kip1 (p27), does not affect stem cell number, cell cycling, or self-renewal, but markedly alters progenitor proliferation and pool size. Therefore, distinct CDKIs govern the highly divergent stem and progenitor cell populations. When competitively transplanted, p27-deficient stem cells generate progenitors that eventually dominate blood cell production. Modulating p27 expression in a small number of stem cells may translate into effects on the majority of mature cells, thereby providing a strategy for potentiating the impact of transduced cells in stem cell gene therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
References
Mauch, P., Ferrara, J. & Hellman, S. Stem cell self-renewal considerations in bone marrow transplantation. Bone Marrow Transplant. 4, 601–607 (1989).
Mauch, P. et al. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 31, 1319–1339 (1995).
Gardner, R.V., Astle, C.M. & Harrison, D.E. Hematopoietic precursor cell exhaustion is a cause of proliferative defect in primitive hematopoietic stem cells (PHSC) after chemotherapy. Exp. Hematol. 25, 495–501 (1997).
Cheng, T. et al. Hematopoietic stem cell quiescence maintained by p21(cip1/waf1). Science 287, 1804–1808 (2000).
Polyak, K. et al. p27kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8, 9–22 (1994).
Sherr, C.J. & Roberts, J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149–1163 (1995).
Sherr, C.J. Cancer cell cycles. Science 274, 1672–1677 (1996).
Kiyokawa, H. et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85, 721–732 (1996).
Fero, M.L. et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85, 733–744 (1996).
Nakayama, K. et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707–720 (1996).
Asiedu, C., Biggs, J. & Kraft, A.S. Complex regulation of CDK2 during phorbol ester-induced hematopoietic differentiation. Blood 90, 3430–3437 (1997).
Liu, M., Iavarone, A. & Freedman, L.P. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J. Biol. Chem. 271, 31723–31728 (1996).
Kranenburg, O., Scharnhorst, V., Van der Eb, A.J. & Zantema, A. Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells. J. Cell. Biol. 131, 227–234 (1995).
Coats, S., Flanagan, W.M., Nourse, J. & Roberts, J.M. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272, 877–880 (1996).
Rivard, N., L'Allemain, G., Bartek, J. & Pouyssegur, J. Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts. J. Biol. Chem. 271, 18337–18341 (1996).
Hengst, L. & Reed, S.I. Translational control of p27Kip1 accumulation during the cell cycle. Science 271, 1861–1864 (1996).
Pagano, M. et al. Role of the ubiquitin–proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 [see comments]. Science 269, 682–685 (1995).
Levine, E.M., Close, J., Fero, M., Ostrovsky, A. & Reh, T.A. p27(Kip1) regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina. Dev. Biol. 219, 299–314 (2000).
Durand, B., Fero, M.L., Roberts, J.M. & Raff, M.C. p27kip1 alters the response of cells to mitogen and is part of a cell- intrinsic timer that arrests the cell cycle and initiates differentiation. Curr. Biol. 8, 431–440 (1998).
Tong, X. & Srour, E.F. TGF-β suppresses cell division of Go CD34+ cells while maintaining primitive hematopoietic potential. Exp. Hematol. 26, 684 (1998).
Taniguchi, T. et al. Expression of p21(Cip1/Waf1/Sdi1) and p27(Kip1) cyclin-dependent kinase inhibitors during human hematopoiesis. Blood 93, 4167–4178 (1999).
Yaroslavskiy, B., Watkins, S., Donnenberg, A.D., Patton, T.J. & Steinman, R.A. Subcellular and cell-cycle expression profiles of CDK-inhibitors in normal differentiating myeloid cells. Blood 93, 2907–2917 (1999).
Dao, M.A., Taylor, N. & Nolta, J.A. Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cell. Proc. Natl. Acad. Sci. USA 95, 13006–13011 (1998).
Ploemacher, R.E., van der Sluijs, J.P., Voerman, J.S. & Brons, N.H. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 74, 2755–2763 (1989).
Ploemacher, R.E., van der Sluijs, J.P., van Beurden, C.A., Baert, M.R. & Chan, P.L. Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse. Blood 78, 2527–2533 (1991).
Mantel, C. et al. Involvement of p21cip-1 and p27kip-1 in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21cip-1 in the maintenance of stem/progenitor cells in vivo. Blood 88, 3710–3719 (1996).
Spangrude, G.J., Heimfeld, S. & Weissman, I.L. Purification and characterization of mouse hematopoietic stem cells Science 241, 58–62 (1988). (Published erratum appears in Science 244, 1030, 1989.)
Gothot, A., Pyatt, R., McMahel, J., Rice, S. & Srour, E.F. Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0 /G1 phase of the cell cycle. Blood 90, 4384–4393 (1997).
Lerner, C. & Harrison, D.E. 5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp. Hematol. 18, 114–118 (1990).
Berardi, A.C., Wang, A., Levine, J.D., Lopez, P. & Scadden, D.T. Functional isolation and characterization of human hematopoietic stem cells. Science 267, 104–108 (1995).
Fadok, V.A. et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148, 2207–2216 (1992).
Muller, A.M. & Dzierzak, E.A. ES cells have only a limited lymphopoietic potential after adoptive transfer into mouse recipients. Development 118, 1343–1351 (1993).
Weston, S.A. & Parish, C.R. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J. Immunol. Methods 133, 87–97 (1990).
Grzegorzewski, K. et al. Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin. J. Exp. Med. 180, 1047–1057 (1994).
Harrison, D.E. Competitive repopulation: a new assay for long-term stem cell functional capacity. Blood 55, 77–81 (1980).
Szilvassy, S.J., Humphries, R.K., Lansdorp, P.M., Eaves, A.C. & Eaves, C.J. Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. Proc. Natl. Acad. Sci. USA 87, 8736–8740 (1990).
Shen, H. et al. Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. J. Virol. 73, 728–737 (1999).
Becker, P.S. et al. Adhesion receptor expression by hematopoietic cell lines and murine progenitors: modulation by cytokines and cell cycle status. Exp. Hematol. 27, 533–541 (1999).
Roy, V. & Verfaillie, C.M. Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: implications for anatomical localization and developmental stage specific regulation of hematopoiesis. Exp. Hematol. 27, 302–312 (1999).
Cheng, T. et al. Temporal mapping of gene expression levels during the differentiation of individual primary hematopoietic cells. Proc. Natl. Acad. Sci. USA 93, 13158–13163 (1996).
Shivdasani, R.A. & Orkin, S.H. The transcriptional control of hematopoiesis [see comments]. Blood 87, 4025–4039 (1996).
Tenen, D.G., Hromas, R., Licht, J.D. & Zhang, D.E. Transcription factors, normal myeloid development, and leukemia. Blood 90, 489–519 (1997).
Testa, U. et al. Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. Blood 88, 3391–3406 (1996).
Carver-Moore, K. et al. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Blood 88, 803–808 (1996).
Shull, M.M. et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359, 693–699 (1992).
Acknowledgements
This work was supported by NIH grants HL 44851, DK 50234, and HL 55718 (D.T.S.), AI07387 and DK02761 (T.C.), the Richard Saltonstall Charitable Foundation (D.T.S.) and the Deutscher Akademischer Austuaschdienst (S.S). The authors thank Andrew Koff (Sloan-Kettering Cancer Center, New York) for p27+/− mice, Youngguang Yang, Nadia Carlesso, and Frederic Preffer for technical assistance and helpful discussions.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Cheng, T., Rodrigues, N., Dombkowski, D. et al. Stem cell repopulation efficiency but not pool size is governed by p27kip1. Nat Med 6, 1235–1240 (2000). https://doi.org/10.1038/81335
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/81335